Results 51 to 60 of about 11,373,870 (247)

Phosphine resistance in saw-toothed grain beetle, Oryzaephilus surinamensis (Coleoptera: Silvanidae) in the United States

open access: yesJulius-Kühn-Archiv, 2018
Sub-lethal dose application of phosphine (PH3) that is mostly caused by leakage during fumigation has resulted in resistance in Tribolium castaneum, Rhyzopertha dominica, Cryptolestes ferrugineus, Sitophilus oryzae, and other stored-product insect pest ...
Hubhachen, Zhaorigetu   +4 more
doaj   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner   +14 more
wiley   +1 more source

Anticoagulant resistance in the UK and a new guideline for the management of resistant infestations of Norway rats (Rattus norvegicus Berk.)

open access: yesJulius-Kühn-Archiv, 2011
Anticoagulant resistance was first discovered in UK Norway rats (Rattus norvegicus Berk.) in 1958 and has been present ever since. The possible detrimental impact of resistance on effective rodent control was quickly recognised and, for almost three ...
Buckle, A.
doaj   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Adopting epidemiological approaches for herbicide resistance monitoring and management

open access: yes, 2020
The widespread use and increasing reliance on herbicides for weed control has resulted in a global epidemic of evolved herbicide resistance in weed populations.
David Comont   +3 more
core   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Factors affecting the rotational use of insecticides for the management of resistance in mosquitoes [PDF]

open access: yes
The rotation of the use of chemically unrelated insecticides has been advocated to delay the build up of resistance. To examine this concept in the laboratory, Anopheles albimanus and Culex guinquefasciatus were subjected
Kasim, S H
core   +1 more source

Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses

open access: yesmBio
The rise in infections caused by multidrug-resistant (MDR) bacteria has necessitated a variety of clinical approaches, including the use of antibiotic combinations.
Kathleen P. Davis   +6 more
doaj   +1 more source

Diapause, cold hardiness and flight ability of Cry1Ac-resistant and -susceptible strains of Helicoverpa armigera (Lepidoptera: Noctuidae)

open access: yesEuropean Journal of Entomology, 2007
The diapause inducement condition, cold hardiness, and flight ability in Cry1Ac-resistant (BtR) and Cry1Ac-susceptible (96S) strains of Helicoverpa armigera (Hübner) were compared in the laboratory.
Ge-Mei LIANG   +3 more
doaj   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy